47
Participants
Start Date
January 18, 2021
Primary Completion Date
March 22, 2022
Study Completion Date
December 31, 2025
CLG
"The development of an innovative device (CLG) consisting of an aqueous gel based on hyaluronic acid and commercially available (Belotero) able to be loaded and to release chemokine CXCL12 recreating a kind of fake niche able to attract immune cells- and CTCs-CXCR4+. The added value is the ability to attract and trap cells capable of leaking out and potentially with a higher metastatic capacity."
Istitute Nazionale Tumori - Fondazione G. Pascale, Napoli
"Istituto Nazionale Tumori - Fondazione G.Pascale, IRCCS", Napoli
National Cancer Institute, Naples
OTHER